Lexaria Bioscience Corp. Quarterly Operating Margin in % from Q3 2023 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lexaria Bioscience Corp. quarterly/annual Operating Margin history and growth rate from Q3 2023 to Q4 2024.
  • Lexaria Bioscience Corp. Operating Margin for the quarter ending November 30, 2024 was -1.47K %, a 31.2% increase year-over-year.
  • Lexaria Bioscience Corp. annual Operating Margin for 2024 was -1.24K %, a 57.1% increase from 2023.
  • Lexaria Bioscience Corp. annual Operating Margin for 2023 was -2.89K %, a 11.5% decline from 2022.
  • Lexaria Bioscience Corp. annual Operating Margin for 2022 was -2.59K %, a 229% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -1.47K +667 +31.2% Sep 1, 2024 Nov 30, 2024
Q3 2024 -1.24K +1.65K +57.1% Jun 1, 2024 Aug 31, 2024
Q2 2024 -1.13K Mar 1, 2024 May 31, 2024
Q1 2024 -1.31K Dec 1, 2023 Feb 29, 2024
Q4 2023 -2.14K Sep 1, 2023 Nov 30, 2023
Q3 2023 -2.89K Jun 1, 2023 Aug 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.